Polymorphisms in Myosin Heavy Chain 9 (MYH9) have also been shown to be associated with CKD risk in admixed non-diabetic nephropathy, and focal segmental glomerulosclerosis (FSGS) [18, 19]. Here, MYH9 is linked to focal segmental glomerulosclerosis.